Serum ω-3 Polyunsaturated Fatty Acids and Potential Influence Factors in Elderly Patients with Multiple Cardiovascular Risk Factors

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Liu, Wenwen ^a   Xie, Xiaochuan ^a   Liu, Meilin ^a   Zhang, Jingwei ^a   Liang, Wenyi ^a   Chen, Xiahuan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; OMEGA 3 FATTY ACID;

AGED; BLOOD; CARDIOVASCULAR DISEASE; COMORBIDITY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, LIQUID; COMORBIDITY; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 85040763874     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-19193-5     Document Type: Article

References (29)

1. Pelliccia, F. et al. Current evidence and future perspectives on n-3 PUFAs. International journal of cardiology 170, S3-7, https://doi. org/10. 1016/j. ijcard. 2013. 06. 044 (2013).
2. Wang, X., Ma, D. W., Kang, J. X. & Kulka, M. n-3 Polyunsaturated fatty acids inhibit Fc epsilon receptor I-mediated mast cell activation. The Journal of nutritional biochemistry 26, 1580-1588, https://doi. org/10. 1016/j. jnutbio. 2015. 07. 027 (2015).
3. Kawauchi, K., Tani, S., Nagao, K. & Hirayama, A. Association of n-3 polyunsaturated fatty acids with soluble thrombomodulin as a marker of endothelial damage: a cross-sectional pilot study. Journal of cardiology 64, 312-317, https://doi. org/10. 1016/j. jjcc. 2014. 02. 004 (2014).
4. Rodrigo, R., Prieto, J. C. & Castillo, R. Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications. Clinical science 124, 1-15, https://doi. org/10. 1042/CS20110663 (2013).
5. Budoff, M. Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease. The American journal of cardiology 118, 138-145, https://doi. org/10. 1016/j. amjcard. 2016. 04. 004 (2016).
6. Gupta, S. Brain food: Clever eating. Nature 531, S12-13, https://doi. org/10. 1038/531S12a (2016).
7. de Oliveira Otto, M. C. et al. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. Journal of the American Heart Association 2, e000506, https://doi. org/10. 1161/ JAHA. 113. 000506 (2013).
8. Jones, P. J. et al. DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial. The American journal of clinical nutrition 100, 88-97, https://doi. org/10. 3945/ ajcn. 113. 081133 (2014).
9. Marchioli, R. & Levantesi, G. n-3 PUFAs in cardiovascular disease. International journal of cardiology 170, S33-38, https://doi. org/10. 1016/j. ijcard. 2013. 06. 042 (2013).
10. Investigators, O. T. et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. The New England journal of medicine 367, 309-318, https://doi. org/10. 1056/NEJMoa1203859 (2012).
11. Risk et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. The New England journal of medicine 368, 1800-1808, https://doi. org/10. 1056/NEJMoa1205409 (2013).
12. Skeie, E. et al. Circulating B-vitamins and smoking habits are associated with serum polyunsaturated Fatty acids in patients with suspected coronary heart disease: a cross-sectional study. PloS one 10, e0129049, https://doi. org/10. 1371/journal. pone. 0129049 (2015).
13. Strand, E. et al. Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study. BMC medicine 11, 216, https://doi. org/10. 1186/1741-7015-11-216 (2013).
14. Tani, S., Takahashi, A., Nagao, K. & Hirayama, A. Association of Fish Consumption-Derived Ratio of Serum n-3 to n-6 Polyunsaturated Fatty Acids and Cardiovascular Risk With the Prevalence of Coronary Artery Disease. International heart journal 56, 260-268, https://doi. org/10. 1536/ihj. 14-243 (2015).
15. Kurisu, S. et al. Effects of ezetimibe on serum polyunsaturated fatty acids in patients with coronary artery disease. International heart journal 54, 254-257 (2013).
16. Yagi, S. et al. Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease. Nutrition journal 13, 112, https://doi. org/10. 1186/1475-2891-13-112 (2014).
17. Tani, S., Nagao, K. & Hirayama, A. Association of atherosclerosis-related markers and its relationship to n-3 polyunsaturated fatty acids levels with a prevalence of coronary artery disease in an urban area in Japan. Heart and vessels 30, 9-19, https://doi. org/10. 1007/s00380-013-0442-y (2015).
18. Kato, S. et al. Relationship between coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance and serum eicosapentaenoic acid. Journal of cardiovascular magnetic resonance: official journal of the Society for Cardiovascular Magnetic Resonance 15, 106, https://doi. org/10. 1186/1532-429X-15-106 (2013).
19. Yu, S. et al. A rapid and precise method for quantification of fatty acids in human serum cholesteryl esters by liquid chromatography and tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 960, 222-229, https://doi. org/10. 1016/j. jchromb. 2014. 04. 040 (2014).
20. Ma, Y. C. et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology: JASN 17, 2937-2944, https://doi. org/10. 1681/ASN. 2006040368 (2006).
21. Mazidi, M. et al. Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24, 182 adult Americans. Lipids in health and disease 16, 192, https://doi. org/10. 1186/s12944-017-0571-x (2017).
22. Mazidi, M., Kengne, A. P., Mikhailidis, D. P., Cicero, A. F. & Banach, M. Effects of selected dietary constituents on high-sensitivity C-reactive protein levels in U. S. adults. Annals of medicine, 1-6, https://doi. org/10. 1080/07853890. 2017. 1325967 (2017).
23. Rifkin, S. B. et al. PUFA levels in erythrocyte membrane phospholipids are differentially associated with colorectal adenoma risk. The British journal of nutrition 117, 1615-1622, https://doi. org/10. 1017/S0007114517001490 (2017).
24. Calder, P. C. & Yaqoob, P. Marine omega-3 fatty acids and coronary heart disease. Current opinion in cardiology 27, 412-419, https:// doi. org/10. 1097/HCO. 0b013e328353febd (2012).
25. Superko, H. R. et al. Omega-3 Fatty Acid Blood Levels Clinical Significance Update. Current cardiovascular risk reports 8, 407, https://doi. org/10. 1007/s12170-014-0407-4 (2014).
26. Mathias, R. A. et al. Adaptive evolution of the FADS gene cluster within Africa. PloS one 7, e44926, https://doi. org/10. 1371/journal. pone. 0044926 (2012).
27. Sekikawa, A., Doyle, M. F. & Kuller, L. H. Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan. Trends in cardiovascular medicine 25, 717-723, https://doi. org/10. 1016/j. tcm. 2015. 03. 001 (2015).
28. Cicero, A. F. G. et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Archives of medical science: AMS 13, 965-1005, https://doi. org/10. 5114/aoms. 2017. 69326 (2017).
29. Siscovick, D. S. et al. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation 135, e867-e884, https://doi. org/10. 1161/ CIR. 0000000000000482 (2017).